Skip to main content
Top
Published in: BMC Nephrology 1/2015

Open Access 01-12-2015 | Research article

Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study

Authors: Leszek Domański, Karolina Kłoda, Ewa Kwiatkowska, Ewa Borowiecka, Krzysztof Safranow, Arleta Drozd, Andrzej Ciechanowicz, Kazimierz Ciechanowski

Published in: BMC Nephrology | Issue 1/2015

Login to get access

Abstract

Background

The outcome of kidney allograft transplantation is associated with numerous donor-dependent and recipient-dependent immunological and non-immunological factors. Studies on genetic factors affecting the non-immunological aspects, like ageing of the kidney allograft and patient outcome are still lacking. The aim of this study was the analysis of relative telomere length (RTL; T/S ratio) in the biopsy specimens of the transplanted kidney allograft and its correlation with the delayed graft function (DGF), acute rejection (AR) and chronic allograft dysfunction (CAD).

Methods

The study enrolled 119 Caucasian kidney allograft recipients (64 M/55 F, mean age 47.32 ± 14.03; transplantation performed between 2001 and 2012). Organs were harvested from cadaveric donors (59.8 M/40.2 F, mean age 45.99 ± 14.62).

Results

There were significant differences in RTL assessed in kidney allograft biopsy specimens collected 3–6 months after transplantation between patients with DGF and without DGF (181.8 ± 82.0 vs. 284.6 ± 149.6; p < 0.05) and in RTL of kidney allograft biopsy specimens collected 18–60 months after transplantation between patients with AR and without AR (188.1 ± 162.1 vs. 263.3 ± 134.7; p = 0.047). There were significant differences in RTL assessed in kidney allograft biopsy specimens collected 12–24 months after transplantation between patients with CAD and without CAD (168.0 ± 120.0 vs. 282.1 ± 158.4; p = 0.038).

Conclusions

Duration of dialysis before transplantation and PRA influence the kidney allograft ageing. Telomere length assessed in biopsy specimens collected in the peri-transplant period predicts the long-term kidney allograft function. Complications of kidney transplantation, like DGF, AR and CAD are linked with the telomere length and thus, graft ageing.
Literature
1.
go back to reference Norin AJ, Mondragon-Escorpizo MO, Brar A, Hochman D, Sumrani N, Distant DA, et al. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study. Hum Immunol. 2013;74:1304–12.CrossRefPubMed Norin AJ, Mondragon-Escorpizo MO, Brar A, Hochman D, Sumrani N, Distant DA, et al. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study. Hum Immunol. 2013;74:1304–12.CrossRefPubMed
2.
go back to reference Moszkowska G, Zielińska H, Zieliński M, Dukat-Mazurek A, Dębska-Ślizień A, Rutkowski B, et al. Identification of patients with increased immunological risk among potential kidney recipients in the Polish population. Hum Immunol. 2014;75:650–5.CrossRefPubMed Moszkowska G, Zielińska H, Zieliński M, Dukat-Mazurek A, Dębska-Ślizień A, Rutkowski B, et al. Identification of patients with increased immunological risk among potential kidney recipients in the Polish population. Hum Immunol. 2014;75:650–5.CrossRefPubMed
4.
go back to reference Krajewska M, Kościelska-Kasprzak K, Weyde W, Drulis-Fajdasz D, Madziarska K, Mazanowska O, et al. Impact of donor-dependent genetic factors on long-term renal graft function. Transplant Proc. 2009;41:2978–80.CrossRefPubMed Krajewska M, Kościelska-Kasprzak K, Weyde W, Drulis-Fajdasz D, Madziarska K, Mazanowska O, et al. Impact of donor-dependent genetic factors on long-term renal graft function. Transplant Proc. 2009;41:2978–80.CrossRefPubMed
5.
go back to reference Kim IW, Moon YJ, Ji E, Kim KI, Han N, Kim SJ, et al. Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients. Eur J Clin Pharmacol. 2012;68:657–69.CrossRefPubMed Kim IW, Moon YJ, Ji E, Kim KI, Han N, Kim SJ, et al. Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients. Eur J Clin Pharmacol. 2012;68:657–69.CrossRefPubMed
6.
go back to reference Kłoda K, Domański L, Pawlik A, Safranow K, Ciechanowski K. The impact of ICAM1 and VCAM1 gene polymorphisms on long-term renal transplant function and recipient outcomes. Ann Transplant. 2013;20:231–7. Kłoda K, Domański L, Pawlik A, Safranow K, Ciechanowski K. The impact of ICAM1 and VCAM1 gene polymorphisms on long-term renal transplant function and recipient outcomes. Ann Transplant. 2013;20:231–7.
7.
go back to reference Kim TH, Jeong KH, Kim SK, Lee SH, Ihm CG, Lee TW, et al. TLR9 gene polymorphism (rs187084, rs352140): association with acute rejection and estimated glomerular filtration rate in renal transplant recipients. Int J Immunogenet. 2013;40:502–8.CrossRefPubMed Kim TH, Jeong KH, Kim SK, Lee SH, Ihm CG, Lee TW, et al. TLR9 gene polymorphism (rs187084, rs352140): association with acute rejection and estimated glomerular filtration rate in renal transplant recipients. Int J Immunogenet. 2013;40:502–8.CrossRefPubMed
8.
go back to reference Gaafar A, Iqniebi A, Sheereen A, Eldali A, Turpeinen H, Adra C, et al. Study of the cytokine polymorphisms in correlation to rejection and graft survival in renal allograft donors and recipients from a homogenous Saudi population. Transpl Immunol. 2014;30:34–9.CrossRefPubMed Gaafar A, Iqniebi A, Sheereen A, Eldali A, Turpeinen H, Adra C, et al. Study of the cytokine polymorphisms in correlation to rejection and graft survival in renal allograft donors and recipients from a homogenous Saudi population. Transpl Immunol. 2014;30:34–9.CrossRefPubMed
9.
go back to reference Chen Z, Bouamar R, Van Schaik RH, De Fijter JW, Hartmann A, Zeier M, et al. Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patients. Clin Transplant. 2014;28:649–55.CrossRefPubMed Chen Z, Bouamar R, Van Schaik RH, De Fijter JW, Hartmann A, Zeier M, et al. Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patients. Clin Transplant. 2014;28:649–55.CrossRefPubMed
10.
go back to reference Oetting WS, Guan W, Schladt DP, Wildebush WA, Becker J, Thyagarajan B, et al. Telomere length of recipients and living kidney donors and chronic graft dysfunction in kidney transplants. Transplantation. 2014;97:325–9.PubMedCentralPubMed Oetting WS, Guan W, Schladt DP, Wildebush WA, Becker J, Thyagarajan B, et al. Telomere length of recipients and living kidney donors and chronic graft dysfunction in kidney transplants. Transplantation. 2014;97:325–9.PubMedCentralPubMed
11.
go back to reference Matsubara Y, Murata M, Yoshida T, Watanabe K, Saito I, Miyaki K, et al. Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochem Biophys Res Commun. 2006;341:128–31.CrossRefPubMed Matsubara Y, Murata M, Yoshida T, Watanabe K, Saito I, Miyaki K, et al. Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochem Biophys Res Commun. 2006;341:128–31.CrossRefPubMed
12.
go back to reference Rodier F, Kim SH, Nijjar T, Yaswen P, Campisi J. Cancer and aging: the importance of telomeres in genome maintenance. Int J Biochem Cell Biol. 2005;37:977–90.CrossRefPubMed Rodier F, Kim SH, Nijjar T, Yaswen P, Campisi J. Cancer and aging: the importance of telomeres in genome maintenance. Int J Biochem Cell Biol. 2005;37:977–90.CrossRefPubMed
13.
go back to reference Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet. 2013;14:1112–20.CrossRefPubMed Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet. 2013;14:1112–20.CrossRefPubMed
14.
go back to reference Morgan RG, Ives SJ, Walker AE, Cawthon RM, Andtbacka RH, Noyes D, et al. Role of arterial telomere dysfunction in hypertension: relative contributions of telomere shortening and telomere uncapping. J Hypertens. 2014;32:1293–9.CrossRefPubMedCentralPubMed Morgan RG, Ives SJ, Walker AE, Cawthon RM, Andtbacka RH, Noyes D, et al. Role of arterial telomere dysfunction in hypertension: relative contributions of telomere shortening and telomere uncapping. J Hypertens. 2014;32:1293–9.CrossRefPubMedCentralPubMed
15.
go back to reference Maubaret CG, Salpea KD, Romanoski CE, Folkersen L, Cooper JA, Stephanou C, et al. Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease. PLoS One. 2013;8:e83122.CrossRefPubMedCentralPubMed Maubaret CG, Salpea KD, Romanoski CE, Folkersen L, Cooper JA, Stephanou C, et al. Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease. PLoS One. 2013;8:e83122.CrossRefPubMedCentralPubMed
16.
go back to reference Melk A, Ramassar V, Helis LMH, Moore R, Rayner D, Solez K, et al. Telomere shortening in kidneys with age. J Am Nephrol. 2000;11:444–53. Melk A, Ramassar V, Helis LMH, Moore R, Rayner D, Solez K, et al. Telomere shortening in kidneys with age. J Am Nephrol. 2000;11:444–53.
17.
go back to reference Ferlicot S, Durrbach A, Bâ N, Desvaux D, Bedossa P, Paradis V. The role of replicative senescence in chronic allograft nephropathy. Hum Pathol. 2003;34:924–8.CrossRefPubMed Ferlicot S, Durrbach A, Bâ N, Desvaux D, Bedossa P, Paradis V. The role of replicative senescence in chronic allograft nephropathy. Hum Pathol. 2003;34:924–8.CrossRefPubMed
18.
go back to reference Joosten SA, van Ham V, Nolan CE, Borrias MC, Jardine AG, Shiels PG, et al. Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am J Pathol. 2003;162:1305–12.CrossRefPubMedCentralPubMed Joosten SA, van Ham V, Nolan CE, Borrias MC, Jardine AG, Shiels PG, et al. Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am J Pathol. 2003;162:1305–12.CrossRefPubMedCentralPubMed
19.
go back to reference Cawthon RM. Telomere length measurement by a novel mono-chrome multiplex quantitative PCR method. Nucleic Acids Res. 2009;37:21.CrossRef Cawthon RM. Telomere length measurement by a novel mono-chrome multiplex quantitative PCR method. Nucleic Acids Res. 2009;37:21.CrossRef
21.
go back to reference Melk A, Schmidt BM, Braun H, Vongwiwatana A, Urmson J, Zhu LF, et al. Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant. 2009;9:114–23.CrossRefPubMed Melk A, Schmidt BM, Braun H, Vongwiwatana A, Urmson J, Zhu LF, et al. Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant. 2009;9:114–23.CrossRefPubMed
22.
go back to reference Sanders JL, Newman AB. Telomere length in epidemiology: a bio-marker of aging, age-related disease, both, or neither? Epidemiol Rev. 2013;35:112–31.CrossRefPubMed Sanders JL, Newman AB. Telomere length in epidemiology: a bio-marker of aging, age-related disease, both, or neither? Epidemiol Rev. 2013;35:112–31.CrossRefPubMed
23.
go back to reference Heidinger BJ, Blount JD, Boner W, Griffiths K, Metcalfe NB, Monaghan P. Telomere length in early life predicts lifespan. Proc Natl Acad Sci U S A. 2012;109:1743–8.CrossRefPubMedCentralPubMed Heidinger BJ, Blount JD, Boner W, Griffiths K, Metcalfe NB, Monaghan P. Telomere length in early life predicts lifespan. Proc Natl Acad Sci U S A. 2012;109:1743–8.CrossRefPubMedCentralPubMed
24.
go back to reference Koppelstaetter C, Schratzberger G, Perco P, Hofer J, Mark W, Ollinger R, et al. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell. 2008;7:491–7.CrossRefPubMed Koppelstaetter C, Schratzberger G, Perco P, Hofer J, Mark W, Ollinger R, et al. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell. 2008;7:491–7.CrossRefPubMed
25.
go back to reference Joosten SA, van Kooten C, Sijpkens YW, de Fijter JW, Paul LC. The pathobiology of chronic allograft nephropathy: immune-mediated damage and accelerated aging. Kidney Int. 2004;65:1556–9.CrossRefPubMed Joosten SA, van Kooten C, Sijpkens YW, de Fijter JW, Paul LC. The pathobiology of chronic allograft nephropathy: immune-mediated damage and accelerated aging. Kidney Int. 2004;65:1556–9.CrossRefPubMed
26.
go back to reference Gingell-Littlejohn M, McGuinness D, McGlynn LM, Kingsmore D, Stevenson KS, Koppelstaetter C, et al. Pre-transplant CDKN2A expression in kidney biopsies predicts renal function and is a future component of donor scoring criteria. PLoS One. 2013;8:e68133.CrossRefPubMedCentralPubMed Gingell-Littlejohn M, McGuinness D, McGlynn LM, Kingsmore D, Stevenson KS, Koppelstaetter C, et al. Pre-transplant CDKN2A expression in kidney biopsies predicts renal function and is a future component of donor scoring criteria. PLoS One. 2013;8:e68133.CrossRefPubMedCentralPubMed
Metadata
Title
Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study
Authors
Leszek Domański
Karolina Kłoda
Ewa Kwiatkowska
Ewa Borowiecka
Krzysztof Safranow
Arleta Drozd
Andrzej Ciechanowicz
Kazimierz Ciechanowski
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2015
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-015-0014-8

Other articles of this Issue 1/2015

BMC Nephrology 1/2015 Go to the issue